Sosa, L.; Espinoza, L.C.; Pujol, A.; Correa-Basurto, J.; Méndez-Luna, D.; Sarango-Granda, P.; Berenguer, D.; Riera, C.; Clares-Naveros, B.; Calpena, A.C.;
et al. Topical Meglumine Antimoniate Gel for Cutaneous Leishmaniasis: Formulation, Evaluation, and In Silico Insights. Gels 2025, 11, 601.
https://doi.org/10.3390/gels11080601
AMA Style
Sosa L, Espinoza LC, Pujol A, Correa-Basurto J, Méndez-Luna D, Sarango-Granda P, Berenguer D, Riera C, Clares-Naveros B, Calpena AC,
et al. Topical Meglumine Antimoniate Gel for Cutaneous Leishmaniasis: Formulation, Evaluation, and In Silico Insights. Gels. 2025; 11(8):601.
https://doi.org/10.3390/gels11080601
Chicago/Turabian Style
Sosa, Lilian, Lupe Carolina Espinoza, Alba Pujol, José Correa-Basurto, David Méndez-Luna, Paulo Sarango-Granda, Diana Berenguer, Cristina Riera, Beatriz Clares-Naveros, Ana Cristina Calpena,
and et al. 2025. "Topical Meglumine Antimoniate Gel for Cutaneous Leishmaniasis: Formulation, Evaluation, and In Silico Insights" Gels 11, no. 8: 601.
https://doi.org/10.3390/gels11080601
APA Style
Sosa, L., Espinoza, L. C., Pujol, A., Correa-Basurto, J., Méndez-Luna, D., Sarango-Granda, P., Berenguer, D., Riera, C., Clares-Naveros, B., Calpena, A. C., Prohens, R., & Silva-Abreu, M.
(2025). Topical Meglumine Antimoniate Gel for Cutaneous Leishmaniasis: Formulation, Evaluation, and In Silico Insights. Gels, 11(8), 601.
https://doi.org/10.3390/gels11080601
